Zurich Cantonal Bank
IONS icon

Zurich Cantonal Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Zurich Cantonal Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,921
Closed -$3.87M – 3020
2025
Q4 		$3.87M Buy
+48,921
New +$3.68M 0.01% 696

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Zurich Cantonal Bank's IONS Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Ionis Pharmaceuticals (IONS) stake by 8% in Q2 2026, buying an estimated $364K and bringing the position to 65,077 shares worth $5.16M. The position accounts for 0.01% of the portfolio, ranked #686.

Zurich Cantonal Bank first reported a position in IONS in Q2 2013 and has held it in 51 quarters since. 516 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Zurich Cantonal Bank held 65,077 shares of Ionis Pharmaceuticals worth $5.16M as of Q2 2026.
  • Zurich Cantonal Bank bought 4,838 Ionis Pharmaceuticals shares in Q2 2026, an estimated $364K.
  • Ionis Pharmaceuticals made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #686 holding.
  • Zurich Cantonal Bank first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • 516 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.